Market Research News

Friday 29 September 2017

Ceiling Tiles Market Expected to reach USD 10.08 billion by 2025 : Grand View Research Inc.

Global Ceiling Tiles Market is expected to reach USD 10.08 billion by 2025, growing at a CAGR of 9.5%, according to a new report by Grand View Research, Inc. Increasing construction of office spaces worldwide is likely to boost the usage of building materials including mineral wool, metal, and gypsum panels by the end of 2025.

Rise in the working population group, since the past few years has led to an increased construction spending in key Asia Pacific countries including China, Vietnam, Bangladesh, Singapore, India, Thailand, and Malaysia. Construction of new offices across the globe is estimated to peak in the future.

This scenario is likely to reflect in developing countries including China, Russia, and India. Furthermore, currently rising foreign investments coupled with government initiatives in these countries is projected to boost the construction of business centers and IT parks in the recent future. These factors are considered to influence the consumption of construction materials including ceiling tiles and hence boost their market growth.

Emerging regions especially Latin America and Middle East & Africa are expected to depict above average industry growth owing to development of the hotel sector as a result of increasing government initiatives regarding the tourism industry in these regions.

Full Research Report on Global Ceiling Tiles Market Analysis:
http://www.grandviewresearch.com/industry-analysis/ceiling-tiles-market

Further key findings from the report suggest:

In terms of revenue, the residential segment is expected to rise at a CAGR of 9.4% over the forecast period. This application segment constituted a revenue share of 4.6% in 2016.
Technological breakthrough in the field of low VOC panels and recyclable tiles is estimated to offer lucrative growth prospects in the industry by the end of 2025. Furthermore, development of three dimensional ceiling tiles is another important milestone that is expected to open new avenues in the industry.
Companies are aiming at achieving optimum business growth through fully integrating their business operations across the product value chain. For instance, USG Corporation is engaged in manufacturing ceiling tiles as well as its precursor gypsum board and has strong distribution network.
In June 2017, Armstrong Ceiling Solutions launched a new range of ceiling tiles under the New Dune eVo brand name. These tiles are 100% recyclable and exhibit well improved aesthetics and acoustic performance.
In April 2014, the Rockfon North America, a ROCKWOOL International subsidiary achieved the UL Environment’s GREENGUARD Gold certification for its low VOC products. This has enhanced the market position of the company as a key sustainable player in the past years.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/automotive-and-aerospace-interior-materials

Grand View Research has segmented the Global Ceiling Tiles Market on the basis of product, application, and region:

Product Outlook (Volume, Million Square Meters; Revenue, USD Million, 2014 - 2025)

Mineral wool
Metal
Gypsum
Others

Application Outlook (Volume, Million Square Meters; Revenue, USD Million, 2014 - 2025)

Commercial Construction
Residential Construction
Industrial Construction

Regional Outlook (Volume, Million Square Meters; Revenue, USD Million, 2014 - 2025)

North America

U.S.

Europe

Germany
UK

Asia Pacific

China
India

Central & South America

Brazil

Middle East & Africa

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-ceiling-tiles-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Membrane Bioreactor Market Projected to reach USD 8.27 billion by 2025 : Grand View Research,Inc.

Global Membrane Bioreactor Market is expected to reach USD 8.27 billion by 2025, according to a new report by Grand View Research, Inc. Rising demand for membrane bioreactor as they offer high-quality solid separation and low carbon footprint will propel industry expansion over the forecast period.

Rising concerns regarding the release of toxic effluents into the environment are expected to result in an increase in the installation of membrane bioreactor solutions in the industrial and manufacturing sector. In addition, stringent environmental regulations on sludge disposal are expected to stimulate demand for highly effective MBR systems.

Increasing MBR installations by various key players including Beijing Origin Water, GE Water, Koch Membrane Systems, and Tianjin MOTIMO as a result of rising industrial wastes by pharmaceuticals, food & beverages, and refinery will promote the market growth over the forecast period. Technology up gradation coupled with cost reductions are expected to drive the product demand over the forecast period.

Municipal accounted for 68.7% of the overall share in 2016 and is expected to witness substantial growth as a result of increasing urban population and government support to promote infrastructure development in Turkey, China, India, Singapore, Thailand, and Bangladesh.

Full Research Report on Global Membrane Bioreactor Market Analysis:
http://www.grandviewresearch.com/industry-analysis/membrane-bioreactor-mbr-market

Further key findings from the report suggest:

Flat sheet MBR is expected to witness significant rise at a CAGR of 18.5% from 2017 to 2025 as a result of increasing adoption in the medium scale industrial waste water treatment plants. Moreover, increasing usage in food & beverage sector owing to its high solid loading and good hydraulic flow behavior is anticipated to fuel demand.
Asia Pacific was the dominant market and accounted for 50.4% of the global membrane bioreactor market in 2016. Establishment of various food & beverage, pharmaceutical, pulp & paper manufacturing units particularly in India and China will fuel MBR demand in industrial waste water sector.
Growing water pollution along with water shortage problems that are currently prevailing in China, India, Singapore and Malaysia is expected to provide ample opportunity for the wastewater treatment industry.
Key participants dominating the membrane bioreactor (MBR) industry includes GE Water & Process Technologies, Toray Industries, Inc., Kubota Corporation, Koch Membrane Systems, Inc., Evoqua Water Technologies LLC, and Mitsubishi Rayon Co., Ltd.
MBR players are adopting numerous strategies for strengthening its foothold across the international market. These companies have been undertaking strategies including new product developments, expansion of installed capacity in order to increase its market penetration.
In July 2015, Cambrian Innovation launched EcoVolt Membrane Bioreactor (MBR). This system will remove over 99% of pollutants and solids, enabling water re-use on site
KMS introduced next generation of improved, high flux PURON modules for membrane bioreactor having built-in reliability, low life-cycle costs, reduced system footprint, and new fiber chemistry

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/water-and-industrial-sludge-treatment

Grand View Research has segmented the Global Membrane Bioreactor (MBR) Market on the basis of product, configuration, application, and region:

Product Outlook (Revenue, USD Million, 2014 - 2025)

Hollow fiber
Flat sheet
Multi-tubular

Configuration Outlook (Revenue, USD Million, 2014 - 2025)

Submerged
Side stream

Application Outlook (Revenue, USD Million, 2014 - 2025)

Municipal
Industrial

Food & beverages
Textile
Oil & gas
Others

Regional Outlook (Revenue, USD Million, 2014 - 2025)

North America

U.S.

Europe

Germany
UK
Italy
France

Asia Pacific

China
Japan

Central & South America

Brazil

Middle East & Africa

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-membrane-bioreactor-mbr-market

Chatbot Market Projected to reach USD 1.25 billion by 2025 : Grand View Research,Inc.

Global Chatbot Market is expected to reach USD 1.25 billion by 2025, growing at a CAGR of 24.3%, according to a new report by Grand View Research, Inc. The chatbot industry is expected to witness significant growth over the forecast period as they enable enterprises to substantially reduce operating costs. Additionally, innovations in artificial intelligence and machine learning technologies are likely to enhance the features of chatbots, which acts as a major driver for the market.

A significant rise has been observed in the number of users of messaging services, which is expected to surpass the number of users of social networking sites. Additionally, there has been a significant development in the NLP field, which has resulted in streamlined interactions between computers and human languages. The entire chatbot ecosystem comprises various cross-linking features, which facilitates enhanced performance of chatbots in all application. Most companies prefer in-built chatbots on their websites as they facilitate enterprises in providing instant customer interaction. For instance, Slack and Twitter messaging platforms are preferred by majority businesses.

North America is expected to emerge as the major region for the chatbot market over the forecast period. The growth in this region is mainly attributed to the increasing deployment of chatbots in various business verticals. Technologies such as artificial intelligence, IoT, and APIs, among others, are evolving at a rapid speed. Chatbots are integrated with these technologies to offer enhanced operations, thereby driving market demand. Artificial intelligence and audio speech-based chatbots are expected to account for the largest market share in future. Additionally, speech recognition has improved drastically, especially in terms of native languages, which is expected to result in enhanced performance of chatbots in various applications.

Full Research Report on Global Chatbot Market Analysis:
http://www.grandviewresearch.com/industry-analysis/chatbot-market

Further key findings from the report suggest:

Chatbots find various applications in e-commerce, healthcare, and BFSI sectors. Large enterprise emerged as the largest end-user segment in 2016 and is estimated to register a CAGR of 24.2% over the forecast period.
The bots for marketing segment is expected to witness the largest growth over the forecast period as these chatbots can connect the customers directly to service providers.
The standalone segment is estimated to grow at a CAGR of 24.8% over the forecast period.
The Asia Pacific market is projected to witness substantial growth over the next decade owing to various technological developments across major economies. The regional market is expected to grow at a CAGR of 24.7 % from 2017 to 2025.

Key participants in the chatbot industry include Baidu, Poncho, Kik, WeChat, Varo Money Inc., Babylon Health, ReplyYes, and SRI International. Chatbots have found wide applications in large enterprises as they enable better understanding of consumer behavior with the help of machine learning.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/communication-services

Grand View Research has segmented the Global Chatbot Market based on end users, applications/business models, types, product landscape, verticals, and regions:

End User Outlook (Revenue, USD Million; 2014 - 2025)

Small Enterprises
Medium Enterprises
Large Enterprises

Application/Business Model Outlook (Revenue, USD Million; 2014 - 2025)

Bots for Service
Bots for Social Media
Bots for Payments/Order Processing
Bots for Marketing
Others

Type Outlook (Revenue, USD Million; 2014 - 2025)

Standalone
Web-based
Messenger-based/Third Party

Product Landscape Outlook (Revenue, USD Million; 2014 - 2025)

Artificial Intelligence
Marketing
Human Intelligence

Vertical Outlook (Revenue, USD Million; 2014 - 2025)

Healthcare
Retail
Banking, Financial Services, and Insurance (BFSI)
Media & Entertainment
Travel & Tourism
E-commerce
Others

Regional Outlook (Revenue, USD Million; 2014 - 2025)

North America

U.S.
Canada
Mexico

Europe

Germany
UK

Asia Pacific

China
Japan
South Korea

South America

Brazil
Rest of South America

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-chatbot-market

Thursday 28 September 2017

Erythropoietin (EPO) Drugs Market Estimated to reach USD 17.4 billion by 2025 : Grand View Research,Inc.

Global Erythropoietin (EPO)Drugs Market is expected to reach USD 17.4 billion by 2025, according to a new report by Grand View Research, Inc. Rising incidence of chronic diseases such as CKD and cancer resulting in anaemia is a major growth driver of this market.

According to the statistics published by the National Heart, Lung, and Blood Institute of the U.S. Department of Health & Human Services, over 3 million people are affected by anemia every year and this number is expected to increase over the forecast period. This showcases the need for erythropoietin-stimulating agents in the coming years.

Introduction of novel drugs and their cheaper biosimilar formulations with enhanced efficacy and cost-effectiveness is also expected to serve this industry with lucrative opportunities. For instance, development of numerous biosimilars in the European market is expected to gain traction and increase their usage rates, owing to associated benefits such as less time required for approval, cost-efficiency, and enhanced therapeutic effect.

Companies are involved in extensive R&D initiatives for development of innovative molecules and discovering new therapeutic areas for existing drugs. For instance, in April 2016, Sandoz received approval from the European Commission for use of its biosimilar Binocrit in nephrology indications, thereby extending the therapeutic area of its product portfolio.

Moreover, many of the industry players in the U.S., Europe, and Asia Pacific are involved in the development of new biosimilars. For example, Biocon’s subsidiary Syngene International entered into an agreement with Bristol-Myers Squibb to extend their drug discovery and development program in India. This enables Biocon to enhance its erythropoietin drugs portfolio. Expected product approvals in the coming years are anticipated to fuel market growth.

Full Research Report on Global Erythropoietin Drugs Market Analysis:
http://www.grandviewresearch.com/industry-analysis/erythropoietin-epo-drugs-market

Further key findings from the study suggest:

The biologics segment is declining over the forecast period owing to patent expiration of branded biologics and introduction of biosimilars in the market
The patent for Aranesp (darbepoetin-alfa) will expire in 2024 in the U.S. and is expected to provide numerous future growth opportunities for new market entrants
Epoetin-alfa held the largest share of product segment owing to its early introduction in the U.S. market and patent protection
Epoetin-omega and epoetin-zeta are anticipated to exhibit lucrative growth over the forecast period owing to associated benefits such as longer half-life and enhanced therapeutic effects
Use of erythropoietin drugs for treatment of renal diseases held a dominant share as of 2016 owing to the increasing incidence of chronic kidney diseases
The Asia Pacific regional industry for erythropoietin-stimulating agents is expected to witness lucrative CAGR during the forecast period
Industry participants are focusing on the discovery of new therapeutic areas for existing drugs and development of cost-effective biosimilars, thereby increasing R&D activities for the development of erythropoietin drugs.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Global Erythropoietin (EPO) Drugs Market on the basis of the drug class, product, application, and region:

Erythropoietin Drugs Drug class Outlook (Revenue, USD Million, 2014 - 2025)

Biologics
Biosimilar

Erythropoietin Drugs Product Outlook (Revenue, USD Million, 2014 - 2025)

Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others

Erythropoietin Drugs Application Outlook (Revenue, USD Million, 2014 - 2025)

Cancer
Hematology
Renal Diseases
Neurology

Erythropoietin Drugs Regional Outlook (Revenue, USD Million, 2014 - 2025)

North America

U.S.
Canada

Europe

Germany
UK

Asia Pacific

Japan
China
India

Latin America

Brazil
Mexico

South Africa

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-erythropoietin-epo-drugs-market

Disposable Medical Sensors Market Projected to reach USD 12.3 billion by 2025 : Grand View Research,Inc.

Global Disposable MedicalSensors Market is expected to reach USD 12.3 billion by 2025, according to a new report by Grand View Research, Inc. Increasing prevalence of chronic diseases has been observed to be a major factor driving growth which is demanding for better healthcare service provision by high quality diagnostic and monitoring devices. These devices will enable patients to self-monitor and along with easy and affordable usage. In addition, the rapidly rising technological advancements is expected to bring in innovation in medical sensors.

The market is also being driven by government initiatives to fund and encourage R&D which in turn will help in launching innovative products. For instance, the government of India increased the health expenditure from 1.4% to 2.5% for innovations, and other healthcare services. Innovations in medical sensors not only instill ease of use but also assist in making the device portable and automated.

On the basis of product, the biosensor segment is accounted to be the spearhead in 2016 and is expected to maintain its dominance over the forecast period. This can be attributed to the rising demand for rapid and accurate diagnostic kit. Development of such diagnostic tools is expected to further create new growth opportunities for biosensors, thereby supporting growth of the disposable medical sensors market. Launching of new products are expected to fuel market growth. For instance, Raiing Medical launched wearable thermometer in 2016 that is rechargeable and waterproof. Similarly, MEMSIC Inc. launched new pressure sensor in 2017 which is used in breath detection.

Full Research Report on Global Disposable Medical Sensors Market Analysis: http://www.grandviewresearch.com/industry-analysis/disposable-medical-sensors-industry

Further Key Findings From the Report Suggest:

Globally, disposable medical sensors witnessed lucrative growth in 2016 and are expected to grow at a CAGR of 10.2% from 2017 to 2025
Biosensor segment has been observed to be the largest product segment in 2016 and is estimated to generate revenue of over USD 6.03 billion by 2025
On the basis of application, the diagnostic segment is expected to dominate the market space. This is attributed to the increasing incidence of various infectious and other chronic conditions, along with the growing awareness among the population.
The industry in Asia Pacific is expected to witness substantial growth over the next decade owing to the increasing incidence of diseases and the geriatric population with high unmet healthcare needs.
Some of the key players in this industry are Medtronic, Philips, GE Healthcare, OmniVision Technologies, Sensiorion AG, Smiths Medical, and Analog Devices.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Global Disposable Medical Sensors Market on the basis of product, distribution channel, end use, and region:

Product Outlook (Revenue, USD Million, 2014 - 2025)

Biosensors
Pressure sensors
Accelerometer sensors
Temperature sensors
Image sensors

Type Outlook (Revenue, USD Million, 2014 - 2025)

Strip sensors
Wearable sensors
Implantable sensors
Invasive sensors
Ingestible sensors

Application Outlook (Revenue, USD Million, 2014 - 2025)

Diagnostic
Therapeutic
Patient monitoring

Regional Outlook (Revenue, USD Million, 2014 - 2025)

North America

U.S.
Canada

Europe

Germany
U.K

Asia Pacific

China
Japan

Latin America

Brazil
Mexico

Middle East Asia

South Africa
Saudi Arabia

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-disposable-medical-sensors-market

Latin America Insulin market Projected to reach USD 3,760.7 million by 2020 : Grand View Research,Inc.

The Latin America Insulin market is expected to reach USD 3,760.7 million by 2020, according to a new study by Grand View Research, Inc. Growing prevalence of diabetes (type I and type II) coupled with government initiatives to develop insulin in markets such as Brazil by providing medical and financial aid to the population in the form of subsidies and the entrance of multinational companies such as Novo Nordisk, Sanofi Aventis, etc is expected to drive regional insulin market. Affordability of medicines is perceived to be a key challenge for market development, as a significant part of the population may not be able to afford the product.

In 2013, Type II applications lead the regional market, with revenue of USD 1,183.7 million and are expected to grow at a CAGR of 15.8 % from 2014 to 2020. Type I applications are expected to have faster growth, at an estimated CAGR of 20.3 % from 2014 to 2020.

Full Research Report on Global Erythropoietin Drugs Market Analysis:
http://www.grandviewresearch.com/industry-analysis/latin-merica-insulin-market

Further key findings from the study suggest:

· Long acting products dominated insulin demand in Latin America, with estimated revenue of USD 548.6 million in 2013. Other leading products include rapid acting and premixed analogs, with the latter expected to grow at a CAGR of 14.3 % from 2014 to 2020.

· In 2013, Analog was a dominant insulin source and is expected to grow at a CAGR of 17.7 % from 2014 to 2020.

· R&D initiatives, changing lifestyle affecting health of people specially children and growing rate of old aged (above 40) population are also expected to have a positive influence on market demand.

· In 2013, Brazil was the largest regional insulin market in terms of revenue, accounting for 38.0% share of Latin American demand, followed by Mexico and Argentina. Brazil insulin demand is estimated to grow at a fastest CAGR of 18.2 % from 2014 to 2020.

· Some of the key manufacturers in Latin American insulin market include Sanofi Aventis, Novo Nordisk, Nanjing Xinbai Pharmaceutical Co. Ltd, Takeda Pharmaceuticals, Eli Lilly and Company.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Asia Pacific Insulin market on the basis of product, application, source and region:

Insulin Product Outlook

· Rapid acting

· Long acting

· Premixed

· Premixed analog

· Short acting

· Intermediate acting

Insulin Application Outlook

· Type II and Other Diabetes

· Type I Diabetes

· Insulin Source Outlook

· Human Recombinant

· Analogs

Insulin Regional Outlook

· Brazil

· Argentina

· Chile

· Mexico

· Colombia

· Venezuela

· Peru

· Rest of Latin America

View Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/latin-america-insulin